Yervoy (ipilimumab) is a medication used for the treatment of melanoma. According to the sources provided, it is unclear whether Yervoy discounts can be combined with insurance. However, there is information available on the cost of Yervoy and its combination therapy with other medications.

Yervoy is a biologic drug that is protected by a patent until 2023 [1]. As a result, it is expensive and not always covered by insurance. According to a study published in JAMA Network Open, the average cost of Yervoy treatment for melanoma patients was $100,000 [2]. The study also found that the cost of Yervoy treatment varied widely depending on insurance coverage and the type of healthcare provider.

Combination therapy with Yervoy and other medications, such as nivolumab (Opdivo), has been shown to be effective in treating melanoma [3]. However, the cost of combination therapy can be even higher than the cost of Yervoy alone.

It is recommended that patients speak with their healthcare provider and insurance company to determine the cost of Yervoy treatment and whether discounts can be combined with insurance. Additionally, organizations such as the Melanoma Research Foundation may be able to provide resources and support for patients seeking treatment for melanoma.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/YERVOY
[2] https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779418
[3] https://www.curemelanoma.org/patient-eng/melanoma-treatment/combination-therapy-for-melanoma/nivolumab-opdivo-ipilimumab-yervoy